tezosentan has been researched along with Recrudescence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, KF; Frey, A; Gattis, WA; Gheorghiade, M; Kobrin, I; O'Connor, CM; Shah, MR | 1 |
| Adams, KF; Frey, A; Gattis, WA; Gheorghiade, M; O'Connor, CM; Shah, MR | 1 |
2 trial(s) available for tezosentan and Recrudescence
| Article | Year |
|---|---|
Tezosentan in patients with acute heart failure and acute coronary syndromes: design of the Randomized Intravenous Tezosentan study (RITZ-4).
Topics: Acute Disease; Adult; Child; Coronary Disease; Double-Blind Method; Endothelins; Female; Heart Failure; Humans; Myocardial Infarction; Pyridines; Recurrence; Syndrome; Tetrazoles; Vasodilator Agents | 2002 |
Tezosentan in patients with acute heart failure and acute coronary syndromes: design of the fourth Randomized Intravenous Tezosentan Study (RITZ-4).
Topics: Double-Blind Method; Endothelin Receptor Antagonists; Endothelin-1; Heart Failure; Humans; Myocardial Ischemia; Pyridines; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Recurrence; Tetrazoles; Treatment Outcome; Vasodilator Agents | 2003 |